You have 9 free searches left this month | for more free features.

Head and Neck Squamous Cell Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Accelerated RTH in Squamous Cell Carcinoma in Head and Neck

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Mar 14, 2022

    Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck Trial

    Not yet recruiting
    • Head and Neck Cancer
    • +4 more
    • Ozuriftamab Vedotin
    • PD-1 inhibitor
    • (no location specified)
    Jul 28, 2022

    Head and Neck Squamous Cell Cancer

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • OncoPrism-HNSCC™
    • San Francisco, California
      Curebase
    Mar 15, 2022

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 9, 2022

    Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    • +4 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Feb 7, 2022

    Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Seoul (Nivolumab)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 27, 2022

    A Study of Nivolumab in Patients With Head and Neck Cancer.

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck
    • Nivolumab
    • Paris Cedex 5, France
      Local Institution
    Mar 23, 2022

    Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

    Withdrawn
    • Head and Neck Squamous Cell Carcinoma
    • +4 more
    • (no location specified)
    Aug 1, 2022

    Head and Neck Squamous Cell Carcinoma, Radiotherapy, Immunotherapy Trial in Wuhan (induction therapy; surgery; radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • induction therapy; surgery; radiotherapy
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Jul 25, 2022

    Decisional Conflicts, Health-related QoL and Satisfaction With

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +9 more
    • Regular care with additionally administration of questionnaires
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Jul 28, 2022

    Head-and-neck Squamous Cell Carcinoma Trial in San Francisco (89Zr-panitumumab IV, Panitumumab)

    Not yet recruiting
    • Head-and-neck Squamous Cell Carcinoma
    • San Francisco, California
      Stanford Cancer Institute
    Jun 14, 2022

    Nivolumab in Squamous Cell Carcinoma of Head & Neck - Patient

    Completed
    • Squamous Cell Carcinoma of the Head and Neck
    • Nivolumab
    • Mount Laurel, New Jersey
      Local Institution
    May 2, 2022

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Houston (18F-FSPG, 11C-Glutamine)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Head and Neck Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 28, 2022

    Sentinel Lymph Node, Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (peritumoral microbubbles and contrast-enhanced

    Recruiting
    • Sentinel Lymph Node
    • Head and Neck Squamous Cell Carcinoma
    • peritumoral microbubbles and contrast-enhanced ultrasonography
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Jun 26, 2022

    Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)

    Recruiting
    • Head and Neck Squamous Carcinoma
    • Shanghai, China
      Shanghai East Hospital
    Sep 22, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Sapropterin diHCl tablets)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Sapropterin dihydrochloride tablets
    • (no location specified)
    Mar 17, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Tazemetostat, Pembrolizumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    May 26, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Cetuximab, Stereotactic radiosurgery)

    Completed
    • Squamous Cell Carcinoma of the Head and Neck
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute
    Feb 10, 2022

    Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial (enoblituzumab, MGA012, MGD013)

    Withdrawn
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of Head and Neck
    • enoblituzumab
    • +2 more
    • (no location specified)
    Feb 4, 2022

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • Nivolumab 480mg and surgical resection
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Feb 25, 2022

    NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +3 more
    • QEQ278
    • (no location specified)
    Jul 14, 2022

    Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Toripalimab+cetuximab)

    Recruiting
    • Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
    Oct 17, 2022

    Head and Neck Squamous Cell Carcinomas Trial (drug, procedure, radiation)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinomas
    • (no location specified)
    Oct 14, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Duarte, Portland (Atezolizumab, Tiragolumab, Immune-modulating

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Duarte, California
    • +1 more
    Aug 16, 2022

    Head and Neck Squamous Cell Carcinoma Trial (pembrolizumab+cisplatin + 5-fluorouracil)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • pembrolizumab+cisplatin + 5-fluorouracil
    • (no location specified)
    Jun 30, 2022